F11R and breast cancer: The lowered F11R/JAM-A expression in MDA-MB-231 cells as compared with two other MEC lines (Fig. 4a) is in accordance with the previously reported negative correlation of JAM-A expression with the metastatic potential of breast cancer cells [19, 20].